NDRA
ENDRA Life Sciences Inc
NASDAQ: NDRA · HEALTHCARE · DIAGNOSTICS & RESEARCH
$4.87
+0.41% today
Updated 2026-04-30
Market cap
$5.98M
P/E ratio
—
P/S ratio
1,838.78x
EPS (TTM)
$-8.93
Dividend yield
—
52W range
$3 – $12
Volume
0.1M
ENDRA Life Sciences Inc (NDRA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.40M | $-842727.00 | $-1.32M | $-3.30M | $-7.70M | $-8.59M | $-10.77M | $-11.12M | $-12.77M | $-9.55M | $-7.40M | $-5.18M |
| Capital expenditures | $275371.00 | $133811.00 | $7862.00 | $7862.00 | $100000.00 | $43595.00 | $51333.00 | $45000.00 | $202577.00 | $33884.00 | $16000.00 | $17280.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $259493.00 | $309837.00 | $230326.00 | $1002.00 | $1367.00 | $1399.00 | $2.10M | $1.44M | $1.20M | $996430.00 | $571924.00 | $329409.00 |
| Free cash flow | $-1.67M | $-976538.00 | $-1.32M | $-3.31M | $-7.80M | $-8.63M | $-10.82M | $-11.17M | $-12.97M | $-9.58M | $-7.42M | $-5.20M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $4.22M | $395551.00 | $121071.00 | $7790.00 | $840.00 | $5233.00 | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $5.46M | $869497.00 | $-297168.00 | $1.05M | — | — | — | — | — |